DRADS Capital

Alsym Energy develops innovative, low-cost rechargeable energy storage technology free of lithium and cobalt. Ideal for stationary storage, maritime shipping, and electric vehicles, their non-flammable and non-toxic materials enable wide-duration storage with performance comparable to lithium-ion at a lower cost.

QuanticAsset develops AI-driven asset management and investment products for high-net-worth family offices and institutional investors.

Angiowave Provides shockwave therapy services intended to offer safe, comfortable treatment for men to optimize sexual performance.

The Live Green Company, founded in 2018 and headquartered in Santiago, Chile, specializes in the development of plant-based food products. The company offers a range of items, including live green burger mixes and live green pancake mixes. Utilizing proprietary deep technology, The Live Green Company focuses on creating consumer packaged goods that are functional, clean, and sustainable. Their innovative approach incorporates artificial intelligence, machine learning, and precision fermentation to enhance research and development processes, allowing for the efficient creation of active functional ingredients. The Live Green Company is committed to promoting a healthier and more sustainable food future.

The Live Green Company, founded in 2018 and headquartered in Santiago, Chile, specializes in the development of plant-based food products. The company offers a range of items, including live green burger mixes and live green pancake mixes. Utilizing proprietary deep technology, The Live Green Company focuses on creating consumer packaged goods that are functional, clean, and sustainable. Their innovative approach incorporates artificial intelligence, machine learning, and precision fermentation to enhance research and development processes, allowing for the efficient creation of active functional ingredients. The Live Green Company is committed to promoting a healthier and more sustainable food future.

Hyperfine is a pioneering medical device company that developed Swoop®, the world's first FDA-cleared point-of-care MRI system. Designed to enhance patient access to critical care, Swoop produces high-quality images rapidly and at a lower cost than conventional MRIs, enabling clinicians to diagnose and treat patients swiftly in various clinical settings.

Zammo.ai empowers businesses to create ChatGPT-like conversational experiences across voice and text channels using their existing web pages, knowledge bases, and documents. This secure, user-friendly platform resides on the customer's Azure tenant, enabling multilingual interactions while ensuring data privacy and compliance.

Founded in 2019, MarvelBiome is a biopharmaceutical company dedicated to harnessing the power of microbes for treating various human diseases. It specializes in isolating, identifying, and characterizing microbial populations for novel therapeutic applications.

ROKIT Healthcare specializes in advanced medical technologies, focusing on hyper-personalized organ regeneration solutions. They employ artificial intelligence and 3D bioprinting to regenerate skin and cartilage organs for patients through surgical procedures.

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s disease, and Wolfram syndrome. Founded in 2013 and based in Cambridge, Massachusetts, the company is best known for its investigational therapy AMX0035, a fixed-dose co-formulation of sodium phenylbutyrate and Taurursodiol. This treatment aims to address the energy crisis within mitochondria and the accumulation of toxic, unfolded proteins in the endoplasmic reticulum, both of which contribute to the progression of neurodegenerative conditions. Through its research and development efforts, Amylyx seeks to provide effective solutions to mitigate the suffering caused by these debilitating diseases.

AZTherapies, Inc. is a biopharmaceutical company based in Boston, Massachusetts, focused on discovering, developing, and commercializing innovative therapies for neurodegenerative diseases, including Alzheimer's, stroke, ALS, and Parkinson's disease. Established in 2011, the company is advancing a clinical-stage pipeline of small molecule drugs designed to address the underlying mechanisms of these conditions, particularly neuroinflammation and the aggregation of amyloid-beta proteins. Its lead candidate, ALZT-OP1, employs a multi-modal approach to potentially halt or slow the progression of Alzheimer's disease, with the Phase 3 COGNITE trial fully enrolled. In addition to Alzheimer's, AZTherapies is also progressing treatments for cognitive impairment following strokes and other related disorders, aiming to enhance the quality of life for aging populations with limited therapeutic options.

REACT Neuro is a Cambridge, Massachusetts-based company focused on improving brain health through an artificial intelligence-driven digital healthcare platform. The platform offers a range of services, including eye-tracking, voice recognition, and assessments of head and body movements, all through personalized virtual reality experiences. By utilizing scientifically validated exams, REACT Neuro quantifies brain health and develops digital biomarkers, specifically designed for multimodal neurophysiological phenotyping, which aids in understanding the aging brain's health. This approach enables patients to monitor their cognitive wellness objectively and supports informed decisions regarding healthy aging.

Predictus BioSciences, Inc. was incorporated in 2010 and is based in West Roxbury, Massachusetts.